RESULTS	Active treatments decreased mean low-density lipoprotein cholesterol ( 0.37 to 0.46 mmol/L [ 14.5 to 17.7 mg/dL ] ) and increased mean triglyceride ( 0.13 to 0.15 mmol/L [ 11.4 to 13.7 mg/dL ] ) compared with placebo .\